Bovine vs. Human Milk-Based Fortifier Study
Primary Purpose
Very Low Birth Weight Infant (<1250g)
Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Human milk-based fortifier
Bovine protein-based fortifier
Sponsored by
About this trial
This is an interventional supportive care trial for Very Low Birth Weight Infant (<1250g)
Eligibility Criteria
Inclusion Criteria:
- <1250g birth weight
- Parent(s) or guardian(s) agree to use donor breastmilk if own mother's milk supply is insufficient
Exclusion Criteria:
- Infant receives formula or a nutrient fortifier prior to randomization
- >day 14 at the time of enrollment and enteral feeds have not commenced
- Infants with major congenital or chromosomal anomalies that could impact growth
- Enrollment in another research study affecting nutritional management during the feeding intervention
- Reasonable potential that the infant will be transferred to a neonatal intensive care unit where the study protocol will not be continued
Sites / Locations
- Izaak Walton Killam Health Centre
- William Osler Health System-Brampton
- William Osler Health System-Etobicoke
- Markham Stouffville Hospital
- Southlake Regional Health Centre
- Lakeridge Health
- Mackenzie Health
- Rouge Valley Health System
- The Scarborough Hospital-General
- The Scarborough Hospital-Birchmount
- North York General Hospital
- Humber River Hospital
- Toronto East General Hospital
- Sunnybrook Health Sciences Centre
- St Michael's Hospital
- Mount Sinai Hospital
- The Hospital for Sick Children
- St Joseph's Health Centre
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Bovine protein-based fortifier
Human milk-based fortifier
Arm Description
Outcomes
Primary Outcome Measures
Feeding tolerance
Percentage of infants with a significant feeding interruption as defined by days feedings held for ≥12 hours OR feeds reduced by >50% (ml/kg/d) not due to a clinical procedure or transitioning to the breast
Secondary Outcome Measures
Growth
Daily weight measurements, weekly length measurements, weekly head circumference measurements, z-scores for anthropometric measures
Full Information
NCT ID
NCT02137473
First Posted
May 6, 2014
Last Updated
November 23, 2021
Sponsor
The Hospital for Sick Children
1. Study Identification
Unique Protocol Identification Number
NCT02137473
Brief Title
Bovine vs. Human Milk-Based Fortifier Study
Official Title
Optimizing Mothers' Milk for Preterm Infants (OptiMoM) Program of Research: Study 2-Bovine vs. Human Milk-Based Fortifier Study
Study Type
Interventional
2. Study Status
Record Verification Date
November 2021
Overall Recruitment Status
Completed
Study Start Date
August 2014 (Actual)
Primary Completion Date
January 2016 (Actual)
Study Completion Date
March 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Hospital for Sick Children
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Most very low birth weight infants accumulate a nutrient deficit in hospital due to minimal nutrient reserves and elevated nutritional requirements which may contribute to poor outcome. Adding nutrients to human milk improves their nutritional status and growth, but it is unclear if adding bovine protein-based fortifiers as is the current standard of care has some unintended negative consequences to neonates. Infants will be randomized to have their feeds (mother's own milk or pasteurized donor breastmilk) nutrient enriched with a human milk-based fortifier or a bovine protein-based fortifier and will be followed in hospital to assess feeding tolerance, growth, gut inflammation, mother's milk and infant gut microbiome, and neonatal morbidity and mortality.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Very Low Birth Weight Infant (<1250g)
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
127 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Bovine protein-based fortifier
Arm Type
Active Comparator
Arm Title
Human milk-based fortifier
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Human milk-based fortifier
Intervention Type
Other
Intervention Name(s)
Bovine protein-based fortifier
Primary Outcome Measure Information:
Title
Feeding tolerance
Description
Percentage of infants with a significant feeding interruption as defined by days feedings held for ≥12 hours OR feeds reduced by >50% (ml/kg/d) not due to a clinical procedure or transitioning to the breast
Time Frame
84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes first
Secondary Outcome Measure Information:
Title
Growth
Description
Daily weight measurements, weekly length measurements, weekly head circumference measurements, z-scores for anthropometric measures
Time Frame
84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes first
Other Pre-specified Outcome Measures:
Title
Other measures of feeding tolerance
Description
Percent and number of days of emesis, gastric aspirates >50% pre-feed volume, abdominal distension (>2 cm), percentage of infants where enteral feeding was terminated and parenteral nutrition had to be commenced, some assessment of the interruption of feeds, how long it takes to reach full enteral feeds (150 ml/kg/d)
Time Frame
84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes first
Title
Gut inflammation
Time Frame
84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes first
Title
Morbidity/mortality composite
Description
Necrotizing enterocolitis, late onset sepsis, chronic lung disease, severe retinopathy of prematurity, death
Time Frame
84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes first
Title
Bayley Scales of Infant and Toddler Development (BSID)-III
Description
Cognitive, language and motor development as assessed by the BSID-III
Time Frame
18-24 months corrected age
Title
Gut microbiota
Time Frame
56 days of age or hospital discharge
10. Eligibility
Sex
All
Maximum Age & Unit of Time
2 Weeks
Eligibility Criteria
Inclusion Criteria:
<1250g birth weight
Parent(s) or guardian(s) agree to use donor breastmilk if own mother's milk supply is insufficient
Exclusion Criteria:
Infant receives formula or a nutrient fortifier prior to randomization
>day 14 at the time of enrollment and enteral feeds have not commenced
Infants with major congenital or chromosomal anomalies that could impact growth
Enrollment in another research study affecting nutritional management during the feeding intervention
Reasonable potential that the infant will be transferred to a neonatal intensive care unit where the study protocol will not be continued
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Deborah L O'Connor, PhD RD
Organizational Affiliation
The Hospital for Sick Children, University of Toronto
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sharon L Unger, MD FRCPC
Organizational Affiliation
Mount Sinai Hospital, University of Toronto
Official's Role
Principal Investigator
Facility Information:
Facility Name
Izaak Walton Killam Health Centre
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3K 6R8
Country
Canada
Facility Name
William Osler Health System-Brampton
City
Brampton
State/Province
Ontario
ZIP/Postal Code
L6R 3J7
Country
Canada
Facility Name
William Osler Health System-Etobicoke
City
Etobicoke
State/Province
Ontario
ZIP/Postal Code
M9V 1R8
Country
Canada
Facility Name
Markham Stouffville Hospital
City
Markham
State/Province
Ontario
ZIP/Postal Code
L3P 7P3
Country
Canada
Facility Name
Southlake Regional Health Centre
City
Newmarket
State/Province
Ontario
ZIP/Postal Code
L3Y 2P9
Country
Canada
Facility Name
Lakeridge Health
City
Oshawa
State/Province
Ontario
ZIP/Postal Code
L1G 2B9
Country
Canada
Facility Name
Mackenzie Health
City
Richmond Hill
State/Province
Ontario
ZIP/Postal Code
L4C 4Z3
Country
Canada
Facility Name
Rouge Valley Health System
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M1E 4B9
Country
Canada
Facility Name
The Scarborough Hospital-General
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M1P 2V5
Country
Canada
Facility Name
The Scarborough Hospital-Birchmount
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M1W 3W3
Country
Canada
Facility Name
North York General Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M2K 1E1
Country
Canada
Facility Name
Humber River Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M3N 1N1
Country
Canada
Facility Name
Toronto East General Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4C 3E7
Country
Canada
Facility Name
Sunnybrook Health Sciences Centre
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4N 3M5
Country
Canada
Facility Name
St Michael's Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5B 1W8
Country
Canada
Facility Name
Mount Sinai Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 1X5
Country
Canada
Facility Name
The Hospital for Sick Children
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 1X8
Country
Canada
Facility Name
St Joseph's Health Centre
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M6R 1B5
Country
Canada
12. IPD Sharing Statement
Citations:
PubMed Identifier
35987195
Citation
Asbury MR, Shama S, Sa JY, Bando N, Butcher J, Comelli EM, Copeland JK, Forte V, Kiss A, Sherman PM, Stintzi A, Taibi A, Tomlinson C, Unger S, Wang PW, O'Connor DL; OptiMoM Feeding Group. Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants. Cell Host Microbe. 2022 Sep 14;30(9):1328-1339.e5. doi: 10.1016/j.chom.2022.07.011. Epub 2022 Aug 19.
Results Reference
derived
PubMed Identifier
35170053
Citation
Hopperton KE, Pitino MA, Walton K, Kiss A, Unger SL, O'Connor DL, Bazinet RP. Docosahexaenoic acid and arachidonic acid levels are correlated in human milk: Implications for new European infant formula regulations. Lipids. 2022 May;57(3):197-202. doi: 10.1002/lipd.12338. Epub 2022 Feb 15.
Results Reference
derived
PubMed Identifier
34254983
Citation
Hopperton KE, Pitino MA, Chouinard-Watkins R, Shama S, Sammut N, Bando N, Williams BA, Walton K, Kiss A, Unger SL, Bazinet RP, O'Connor DL. Determinants of fatty acid content and composition of human milk fed to infants born weighing <1250 g. Am J Clin Nutr. 2021 Oct 4;114(4):1523-1534. doi: 10.1093/ajcn/nqab222.
Results Reference
derived
PubMed Identifier
32154499
Citation
Hopperton KE, O'Connor DL, Bando N, Conway AM, Ng DVY, Kiss A, Jackson J, Ly L; OptiMoM Feeding Group; Unger SL. Nutrient Enrichment of Human Milk with Human and Bovine Milk-Based Fortifiers for Infants Born <1250 g: 18-Month Neurodevelopment Follow-Up of a Randomized Clinical Trial. Curr Dev Nutr. 2019 Nov 12;3(12):nzz129. doi: 10.1093/cdn/nzz129. eCollection 2019 Dec.
Results Reference
derived
PubMed Identifier
29878061
Citation
O'Connor DL, Kiss A, Tomlinson C, Bando N, Bayliss A, Campbell DM, Daneman A, Francis J, Kotsopoulos K, Shah PS, Vaz S, Williams B, Unger S; OptiMoM Feeding Group. Nutrient enrichment of human milk with human and bovine milk-based fortifiers for infants born weighing <1250 g: a randomized clinical trial. Am J Clin Nutr. 2018 Jul 1;108(1):108-116. doi: 10.1093/ajcn/nqy067. Erratum In: Am J Clin Nutr. 2019 Aug 1;110(2):529. Am J Clin Nutr. 2020 May 1;111(5):1112.
Results Reference
derived
Learn more about this trial
Bovine vs. Human Milk-Based Fortifier Study
We'll reach out to this number within 24 hrs